Abstract CT067: A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer

Jaime Merchan; Jordi Rodon; Gerald Falchook; Shree Venkat; Derek Ostertag; Dalissa Tejera; Thian Kheoh; Douglas J Jolly; Harry E Gruber; Jolene S Shorr

doi:10.1158/1538-7445.AM2018-CT067

Back

Abstract CT067: A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer

Journal article

Peer reviewed

Abstract CT067: A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer

Jaime Merchan, Jordi Rodon, Gerald Falchook, Shree Venkat, Derek Ostertag, Dalissa Tejera, Thian Kheoh, Douglas J Jolly, Harry E Gruber and Jolene S Shorr

Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.CT067-CT067

2018-07-01

DOI: https://doi.org/10.1158/1538-7445.AM2018-CT067

Metrics

12 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Abstract CT067: A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer
Creators: Jaime Merchan
Jordi Rodon
Gerald Falchook
Shree Venkat
Derek Ostertag
Dalissa Tejera
Thian Kheoh
Douglas J Jolly
Harry E Gruber
Jolene S Shorr
Publication Details: Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.CT067-CT067
Academic Unit: Miller School of Medicine; UMMG Dept of Interventional Radiology; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600851102976